home / stock / atbpf / atbpf short
Short Information | Antibe Therapeutics (OTCMKTS:ATBPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 331,143 |
Total Actual Volume | 1,201,163 |
Short Trends | |
---|---|
Cover Days | 13 |
Short Days | 4 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 16,557 |
Average Short Percentage | 28.02% |
Is there a ATBPF Short Squeeze or Breakout about to happen?
See the ATBPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-08-2024 | $0.1889 | $0.2156 | $0.2452 | $0.1889 | 33,935 | 6,750 | 19.89% |
04-05-2024 | $0.2263 | $0.19 | $0.2263 | $0.18865 | 22,355 | 9,050 | 40.48% |
04-04-2024 | $0.2 | $0.2086 | $0.225 | $0.2 | 115,129 | 43,840 | 38.08% |
04-03-2024 | $0.15 | $0.19418 | $0.2146 | $0.15 | 151,112 | 30,412 | 20.13% |
04-02-2024 | $0.1113 | $0.1358 | $0.14 | $0.1113 | 46,700 | 5,400 | 11.56% |
04-01-2024 | $0.165 | $0.1153 | $0.1732 | $0.1113 | 181,162 | 30,246 | 16.7% |
03-26-2024 | $0.32465 | $0.3233 | $0.32465 | $0.318925 | 11,075 | 825 | 7.45% |
03-22-2024 | $0.3146 | $0.31 | $0.3342 | $0.31 | 52,076 | 2,500 | 4.8% |
03-21-2024 | $0.3057 | $0.3146 | $0.3146 | $0.3057 | 21,936 | 2,536 | 11.56% |
03-20-2024 | $0.3116 | $0.3057 | $0.3116 | $0.3057 | 45,159 | 2,734 | 6.05% |
03-19-2024 | $0.3254 | $0.30665 | $0.3254 | $0.302 | 49,842 | 500 | 1% |
03-15-2024 | $0.3307 | $0.324905 | $0.3307 | $0.324905 | 964 | 625 | 64.83% |
03-14-2024 | $0.34915 | $0.3337 | $0.350527 | $0.3337 | 44,970 | 31,970 | 71.09% |
03-13-2024 | $0.3403 | $0.3582 | $0.3582 | $0.3303 | 23,344 | 17,344 | 74.3% |
03-12-2024 | $0.34 | $0.3426 | $0.3426 | $0.34 | 10,500 | 500 | 4.76% |
03-08-2024 | $0.3594 | $0.3369 | $0.367285 | $0.3351 | 7,140 | 527 | 7.38% |
03-07-2024 | $0.406 | $0.39 | $0.4112 | $0.39 | 68,710 | 15,192 | 22.11% |
03-06-2024 | $0.4025 | $0.3881 | $0.433 | $0.3179 | 79,253 | 45,905 | 57.92% |
03-05-2024 | $0.3855 | $0.39604 | $0.40188 | $0.38 | 45,325 | 21,500 | 47.44% |
03-04-2024 | $0.3311 | $0.38986 | $0.4275 | $0.24 | 190,476 | 62,787 | 32.96% |
News, Short Squeeze, Breakout and More Instantly...
Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial Order under the Companies' Creditors Arrangement Act (the " CCAA "), has been granted by the Ontario Sup...
Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the Ontario Superior Court of Justice (Commercial List) (the " Court ") for an Initial Order under the Companies'...
Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (“FDA”) that otenaproxesul has been placed on clinical...